Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

5.670
+0.0601.07%
Volume:190.00K
Turnover:1.07M
Market Cap:3.95B
PE:11.57
High:5.695
Open:5.610
Low:5.610
Close:5.610
52wk High:7.612
52wk Low:5.029
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:0.58
T/O Rate:0.10%
Dividend:0.17
Dividend Rate:3.09%
EPS(LYR):0.490
ROE:4.10%
ROA:2.39%
PB:0.64
PE(LYR):11.57
PS:0.40

Loading ...

Hong Kong Market Midday Update: Hang Seng Index Down 1.13%, Tech Index Falls 2.21%; Tech and Gold Stocks Weaken, Healthcare Sector Gains; Huajian Future Plunges 46% on Debut

Deep News
·
Jun 23

Xinhua Pharmaceutical Gets Trial Nod for Postoperative Pain Drug in China

MT Newswires Live
·
Jun 22

Xinhua Pharmaceutical Secures NMPA Approval to Initiate Clinical Trials for Innovative Analgesic LXH-2103

Bulletin Express
·
Jun 22

Shandong Xinhua Pharmaceutical Receives Regulatory Clearance for Clinical Trial of LXH-2103 Injection

Stock News
·
Jun 22

AH Share Premium and Deviation Rankings as of June 18th

Stock News
·
Jun 18

AH Share Premium and Deviation Data for June 9th

Stock News
·
Jun 09

AH Share Premium and Deviation Data for June 8th

Stock News
·
Jun 08

AH Premium and Deviation Rankings for June 4th

Stock News
·
Jun 04

Key Corporate Updates from Hong Kong-Listed Firms: Drug Approvals, A-Share Plans, and May Sales Figures

Stock News
·
Jun 02

Xinhua Pharmaceutical obtains Chinese approval for Sevelamer Carbonate suspension

Bulletin Express
·
Jun 01

Shandong Xinhua Pharmaceutical Receives Drug Registration Certificate for Sevelamer Carbonate Dry Suspension

Stock News
·
Jun 01

AH Share Premium and Deviation Rankings as of May 29 Close

Stock News
·
May 29

AH Premium and Deviation Rankings as of May 27th

Stock News
·
May 27

Shandong Xinhua: Shareholders Asked to Confirm Attendance for 2025 AGM on 26 June 2026

Bulletin Express
·
May 26

Shandong Xinhua Pharmaceutical Unveils AGM Agenda, Share Capital Update and Auditor Re-appointment

Bulletin Express
·
May 26

AH Premium and Deviation Rankings as of May 25th

Stock News
·
May 25

Xinhua Pharma's Anxiety Drug Passes Chinese Regulator's Quality Consistency Evaluation; Secures Approval

MT Newswires Live
·
May 18

SHANDONG XINHUA Announces Successful Generic Drug Consistency Evaluation for Phenobarbital Tablets

Stock News
·
May 18

Xinhua Pharma Secures Registration Certificate for Respiratory Oral Solution in China

MT Newswires Live
·
May 11

Xinhua Pharmaceutical obtains NMPA approval for Ambroxol-Clenbuterol oral solution

Bulletin Express
·
May 11